23andMe, the at-home DNA testing company backed in part by Alphabet, is now offering the first FDA-approved $199 test for a handful of genetic disease risks, and provide the results directly back to consumers -- without a doctor's note. Consumers could use the tests to find out if they have a genetic risk for diseases like Parkinson's or Alzheimer's....